A buyer-facing site is read as one commercial system.
The diagnosis starts from public pages, metadata, trust routes, docs, schema, CTAs, and answer-engine surfaces.
ProofLayered packages the diagnosis workflow so a buyer can move from public URL to signed report, fix-pack handoff, and an evidence-backed recovery plan.
The experience
Follow the commercial sequence from public evidence to signed recovery work without decoding a raw audit dashboard.
The diagnosis starts from public pages, metadata, trust routes, docs, schema, CTAs, and answer-engine surfaces.
Leadership gets one constraint to act on first instead of a long generic checklist with no commercial order.
Visitor and contract context turns the public diagnosis into a decision case, while avoiding revenue guarantees.
Each pack names the owner, artifact, expected outcome, validation path, and signed evidence record.
Buyer intent map
ProofLayered turns this intent into visible public evidence, structured context, and fix packs that a leadership team can approve.
The paid diagnosis starts with a secure checkout, then turns the submitted company URL into a signed business case.
Each report is designed to be shared internally with leadership, marketing, sales, and engineering.
After the $490 diagnosis, the recovery priority can become internal implementation work, a focused ProofLayered fix-pack sprint, or monitoring of the public proof layer.
Implementation, private analytics review, and ongoing monitoring are separate follow-on decisions so the first purchase stays a low-risk diagnosis, not a disguised retainer.
ProofLayered continues the diagnosis workflow for the submitted company URL and prepares the signed report with prioritized fix packs.
Yes. The report is designed as a leadership-ready decision record with evidence, impact, and fix-pack recommendations.
Yes. After the bottleneck is proven, a team can use the fix packs internally, request focused implementation support, or monitor the public proof layer. Those follow-on options are separate from the $490 diagnosis.
Separating the diagnosis keeps the first purchase focused on the decision: which public blocker should be fixed first. Implementation and monitoring make more sense after the evidence-backed priority is agreed.